Indeed, there are numerous disease states in which NRF2 activation and NLRP3 inhibition are known to be beneficial including neurodegenerative diseases, metabolic diseases, gastrointestinal diseases, and autoimmune disorders. The gene discussed is NLRP3; the disease is metabolic disease.